Download Poster (308.84 KB)

Publication
  • AMCP Nexus •
  • 28 October, 2025 •
  • •

Economic Burden of Cytopenia in Patients with Myelofibrosis: Analysis of a US National Administrative Claims Database

Aaron T Gerds, Lucia Masarova, Michael Marrone, Nichole M Engel-Nitz, Jeffrey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg , Yong Zhu, Lindsay AM Rein

Available materials

Poster
Publication
  • AMCP Nexus •
  • 28 October, 2025 •
  • •

Economic Burden of Macrophage Activation Syndrome (MAS) in Patients With Still’s Disease (Systemic Juvenile Idiopathic Arthritis [sJIA] and Adult-onset Still’s Disease [AOSD]): Analysis of a US National Administrative Claims Database

Michael Marrone, Christopher McPherson, Abiola Oladapo

Available materials

Poster
Publication
  • AMCP Nexus •
  • 28 October, 2025 •
  • •

Transfusion-Related Cost and Time Burden Offsets in Patients With Myelofibrosis Treated With Pacritinib Compared to Best Available Therapy Based on PERSIST-2 Trial

Abiola Oladapo, Karisse Roman-Torres, Aaron Thomas Gerds, Stephen Oh

Available materials

Poster
Publication
  • ASH •
  • 8 December, 2025 •
  • •

Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study

María Eva Mingot Castellano, María Teresa Álvarez Román, María Luisa Lozano, Wolfgang Miesbach, Hafiz Qureshi, Vickie McDonald, Jessica Zhang, Viridiana Cano Garcia, Nina Skuban

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Real-world treatment patterns & outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the real-AVA 3.5 study

Caroline Piatek, Abiola Oladapo, Scott Kolodny, Michael Vredenburg , Sarah Lucht, Emily Bland, Prathamesh Pathak, Bruce Feinberg, Hillary Maitland

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Real-world safety and efficacy of avatrombopag in adults with immune thrombocytopenia: A systematic review and meta-analysis

María Luisa Lozano, David Valcarcel

Publication
  • JSH •
  • 10 October, 2025 •
  • •

One-year efficacy and safety of avatrombopag for chronic immune thrombocytopenia in Japanese adults

Hiroki Yamaguchi, Masaki Iino, Yoshiaki Tomiyama , Harumi Kamiya, Jessica Zhang, Nina Skuban

Available materials

Oral Presentation
Sign up for alerts